Entacapone: all 22 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Entacapone Plus Bevacizumab for Glioblastoma at First RecurrenceNot yet recruitingNCT07831187Phase 1/2
- Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's DiseaseRecruitingNCT06236230Phase 4
- Pilot Study of Entacapone for Methamphetamine AbuseCompletedNCT02058966Early Phase 1Results posted
- A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066CompletedNCT01130493Phase 3Results posted
- Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing OffTerminatedNCT00642356Phase 4Results posted
- Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedNCT00547911Phase 1/2Results posted
- Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-offCompletedNCT00391898Phase 4Results posted
- Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's DiseaseCompletedNCT00219284Phase 4Results posted
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa TherapyCompletedNCT00099268Phase 3Results posted
- Entacapone Combination With Imatinib for Treatment of GISTCompletedNCT04006769Early Phase 1
- Effect of Entacapone on Bodyweight Loss in Obese PopulationStatus unknownNCT02349243Phase 1/2
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)CompletedNCT01437293Phase 1
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) InhibitorsCompletedNCT00906828Phase 4
- Pharmacokinetic Study With Repeated Doses of StalevoCompletedNCT00693862Phase 1
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing OffWithdrawnNCT00601978Phase 4
- Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
- Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.CompletedNCT00247247Phase 4
- An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United StatesCompletedNCT00237263Phase 2
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)CompletedNCT00200447Phase 2
- Entacapone Augmentation for SchizophreniaCompletedNCT00192855Not applicable
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United StatesCompletedNCT00143026Phase 4
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaCompletedNCT00134966Phase 3